manishamkashid
1+ Views

Global Bronchodilators Market

Global Bronchodilators Market was valued at $XX Mn in 2019 and is expected to reach $XX Mn in 2027, registering a CAGR of XX % during the forecast period.
Market Overview:
Bronchodilators are the medications prescribed to the individuals having difficulty in breathing. Bronchodilators help to open the airways or bronchial tubes of the lungs by relaxing the bronchial muscles & allow people to breathe well. Bronchodilators are used to treat various respiratory conditions such as Asthma, Chronic Obstructive Pulmonary Disease (COPD) and Allergic Reactions. Asthma affects 5-10% of the population or an estimated 23.4 million people, including 7 million children. There are two forms of Bronchodilators:
 Short-acting beta-adrenergic bronchodilators which provide quick relief from asthma.
 Long-acting beta-adrenergic bronchodilators are used for preventing asthma attacks or reducing the frequency of symptoms.
An increase in the prevalence of asthma and COPD and advancement in technologies drive the global bronchodilators market. Also, the increase in the number of government initiatives and rising healthcare expenditure is expected to fuel the market over the forecast period. Other factors such as the rise in the incidence of chronic respiratory disease due to cigarette smoking also boost the market growth.
On the other hand, several side effects associated with bronchodilators such as migraine headaches, nausea, bronchitis, etc. may hinder the growth of the market. Cost of treatment and lack of patient awareness may hamper the growth of the market to some extent. Nevertheless, development in emerging economies is expected to create an array of opportunities in the near future.
Regional Insights:
Global Bronchodilators Market
According to the regional analysis, North America is expected to dominate the global bronchodilators market due to a rise in the incidence of chronic respiratory diseases, increase in awareness, rising adoption of nasal therapeutics, and presence of leading players of bronchodilators market such AstraZeneca, Teva Pharmaceuticals, etc.
Followed by North America, Europe is also expected to dominate the global market. Rising cases of COPD and Asthma are driving the market growth. An estimated 1.2 million people are living with diagnosed COPD, according to the British Lung Foundation. Moreover, around 2% of the whole population and 4.5% of all people aged over 40 live with diagnosed COPD in the UK. APAC region is anticipated to be the fastest-growing region during the forecast period owing to the surge in increasing asthma patients.
Market Segmentation:
The global Bronchodilators market is segmented based on Drug Class and Route of Administration:
By Drug-Class:
• Adrenergic Bronchodilators
• Anticholinergic Bronchodilators
• Bronchodilator Combinations
• Methylxanthines
By Application:
• Asthma
• COPD
• Others
By Route of Administration:
• Oral
• Injectable
• Nasal
Drug-Class Segment Analysis:
The Adrenergic Bronchodilators drug class is expected to hold the largest share during the forecast period due to their potency to treat asthma and obstructive lung disease. Adrenergic drugs dilate the bronchial airways by relaxing the surrounding muscles.

Global Bronchodilators Market1
Key players operating in Global Bronchodilators Market:
• F. Hoffmann-La Roche
• Vectura group
• Abbott Laboratories
• Gilead Sciences
• Novartis AG
• Boehringer Ingelheim
• GlaxoSmithKline
• Merck & Co.
• Astrazeneca
• Pfizer
• Teva Pharmaceuticals
• Varenyam Healthcare Pvt. Ltd.
• Xencor
• Pieris pharmaceuticals
• Century pharmaceuticals Limited
• Pharmaxis
• Adamis Pharmaceuticals
• NeoPharm Inc
• Paradigm Biopharmaceuticals
• Prolexys Pharmaceuticals
• Pulmatrix Inc.
The objective of the report is to present a comprehensive analysis of the Global Bronchodilators Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that includes market leaders, followers, and new entrants. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analysed, which will give a clear futuristic view of the industry to the decision-makers.
The report also helps in understanding Global Bronchodilators Market dynamics, structure by analyzing the market segments and project the Global Bronchodilators Market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the Global Bronchodilators Market make the report investor’s guide.
This Report Is Submitted By : Maximize Market Research Company
Customization of the report:
Maximize Market Research provides free personalized of reports as per your demand. This report can be personalized to meet your requirements. Get in touch with us and our sales team will guarantee provide you to get a report that suits your necessities.
About Maximize Market Research:
Maximize Market Research provides B2B and B2C research on 20,000 high growth emerging opportunities & technologies as well as threats to the companies across the Healthcare, Pharmaceuticals, Electronics & Communications, Internet of Things, Food and Beverages, Aerospace and Defense and other manufacturing sectors.
1 Like
0 Shares
Comment
Suggested
Recent